|
|
||||||||
Ann Thorac Surg 2006;82:243-248
© 2006 The Society of Thoracic Surgeons
B and Its Clinical Significance in Nonsmall-Cell Lung Cancer
a Department of Lung Cancer, Affiliated Cancer Hospital, Tian Jin Medical University, Tian Jin, China
b Department of Thoracic Surgery, Affiliated Tumor Hospital, Ha Er Bin Medical University, Ha Er Bin, China
c Department of Epidemiology, China Medical University, Shen Yang, China
d Department of Thoracic Surgery, Tumor Hospital of Liao Ning Province, Shen Yang, China
Accepted for publication January 10, 2006.
* Address correspondence to Dr Wang, Department of Lung Cancer, Affiliated Cancer Hospital, Tian Jin Medical University, Huan Hu Xi St, Tian Jin City, China 300060 (Email: wangchangli1973{at}yahoo.com).
BACKGROUND: It has been known that transcription factor nuclear factor (NF)-
B plays an important role in cell proliferation and oncogenesis. The aims of this study were to evaluate expression levels of NF-
B in nonsmall-cell lung cancer (NSCLC) and to elucidate its clinical significance and prognostic value for patients with NSCLC.
METHODS: Using 45 tumor tissue specimens from 45 patients with NSCLC who underwent surgery, we investigated the expression of NF-
B using Western blotting analysis. Apoptotic rate of NSCLC cells with different expression of NF-
B was determined by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling) assay. Paraffin-embedded tissue blocks from 71 consecutive patients with NSCLC were obtained for immunohistochemical staining.
RESULTS: The expression level of NF-
B in poorly or moderately differentiated lung cancer cells was higher than that in well-differentiated ones (p = 0.001). The apoptotic rate was lower for lung cancer cells with higher NF-
B expression than for those with lower NF-
B expression (p = 0.0238). Furthermore, expression of NF-
B was correlated with caspase-3, cyclooxygenase-2, and p53 expression in lung cancer cells that were examined. Most NSCLC cells showed nuclear staining pattern and the nuclear positive rate was 67.6% (48 of 71 specimens). Immunohistochemical NF-
B expression in patients with NSCLC was an independent prognostic factor for overall survival.
CONCLUSIONS: The results of this study suggest that expression of NF-
B may correlate with lung cancer differentiation. Overexpression of NF-
B inhibits tumor cell apoptosis and indicates an unfavorable prognosis for overall survival in some patients with NSCLC.
This article has been cited by other articles:
![]() |
X. Liu, B. Wang, X. Ma, and Y. Guo NF-{kappa}B Activation Through the Alternative Pathway Correlates with Chemoresistance and Poor Survival in Extranodal NK/T-cell Lymphoma, Nasal Type Jpn. J. Clin. Oncol., July 1, 2009; 39(7): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Tew, E. L. Lorimer, T. J. Berg, H. Zhi, R. Li, and C. L. Williams SmgGDS Regulates Cell Proliferation, Migration, and NF-{kappa}B Transcriptional Activity in Non-small Cell Lung Carcinoma J. Biol. Chem., January 11, 2008; 283(2): 963 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Korst Invited commentary. Ann. Thorac. Surg., July 1, 2006; 82(1): 248 - 248. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |